WeLeader Biomedical Co

WeLeader Biomedical Co EBIT per Share

The EBIT per Share of WeLeader Biomedical Co (7713.TWO) as of Oct 10, 2026 is 5.74 TWD. In the previous year, EBIT per Share was 4.75 TWD — a change of 20.89% (higher).

EBIT per Share

5.74TWD

YoY

20.89%

Last updated:

EBIT per Share of WeLeader Biomedical Co is 2025 5.74 TWD. EBIT per Share of WeLeader Biomedical Co was 2024 4.75 TWD. It decreases by 20.89% higher compared to the previous year.

The WeLeader Biomedical Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
1.65 TWD
Jan 1, 2021
3.19 TWD
Jan 1, 2022
4.67 TWD
Jan 1, 2023
4.75 TWD
Jan 1, 2025
5.74 TWD
Jan 1, 2026 (e)
6.08 TWD
The WeLeader Biomedical Co EBIT per Share history
YEAREBIT per ShareYoY
est6.08TWD+5.85%
5.74TWD+20.89%
4.75TWD+1.74%
4.67TWD+46.32%
3.19TWD+93.52%
1.65TWD—
Access this data via the Eulerpool API
Get Free API Key

WeLeader Biomedical Co Stock analysis

What does WeLeader Biomedical Co do? WeLeader Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about WeLeader Biomedical Co stock

EBIT per Share of WeLeader Biomedical Co is 5.74 TWD in 2025.

EBIT per Share of WeLeader Biomedical Co changed from 4.75 TWD to 5.74 TWD, representing a 20.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share WeLeader Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — WeLeader Biomedical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — WeLeader Biomedical Co